arrow
T

Takayuki Sumiyoshi

kyoto university
H指数:14
被引数:680

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical value of prostate-specific antigen halving time as a predictor of response to first-line systemic treatment for synchronous metastatic castration-sensitive prostate cancer

前列腺特异性抗原半衰期作为同步转移性去势敏感前列腺癌一线系统性治疗效果预测指标的临床价值

2026-08-250
PRE
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft model

IL-8阻断增强下一代患者源性异种移植模型中肾细胞癌的抗PD-1治疗活性

2026-06-010
OAAI
Association between preoperative interruption of antiplatelet therapy and postoperative thrombotic risk after minimally invasive surgery for abdominopelvic cancer in patients treated with P2Y12 inhibitors

腹盆腔癌患者接受P2Y12抑制剂治疗后,围手术期抗血小板治疗中断与微创手术后血栓风险之间的关联

2026-01-160
OAAI
Online adaptive radiation therapy for muscle-invasive bladder cancer: short-course and high-precision definitive treatment for elderly or medically fragile patients

肌肉浸润性膀胱癌的在线自适应放射治疗:老年或医疗状况不稳定患者的短疗程和高精度根治性治疗

2025-10-100
OA
Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell Carcinoma

pT3aN0M0透明细胞肾细胞癌患者预后的风险分层

2025-09-010
PRE
The Clock and the Scalpel: Does delayed Robot-assisted radical prostatectomy affect pathological progression and upgrading in prostate cancer?

《时钟与手术刀:延迟机器人辅助根治性前列腺切除术是否影响前列腺癌的病理进展和升级?》

2025-07-280
PRE
Reevaluating the therapeutic role of extended lymph node dissection in the era of robot-assisted radical prostatectomy

重新评估机器人辅助根治性前列腺切除术时代扩大淋巴结清扫的 therapeutic role。

2025-05-210
OA
Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study

阿司匹林对机器人辅助前列腺癌根治术后生化复发影响的多中心回顾性队列研究

2025-01-150
OAAI
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
2024-03-112
OAAI
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
2024-02-2813
OAAI
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
2023-11-187
OA
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial

CALGB 90203 3期试验中新辅助治疗后前列腺癌的分子特征

2023-09-074
PRE
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

转移性去势抵抗性前列腺癌中循环肿瘤DNA分数的早期治疗变化以及对恩扎鲁他胺或阿比特龙的反应

2023-03-3016
OA
Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model
2023-03-234
OAAI